Aedicell, Inc – Trademark Portfolio

Entity Type: 03

Aedicell, Inc holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include AEDICELL, DERMAVEST, PLURIVEST, and FROM LIFE. FOR LIFE.. The owner is based in Rochester, NY.

100 Latona Rd Bldg 318 Door A

Rochester, NY 14652

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Aedicell, Inc's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Aedicell, Inc have?

Aedicell, Inc has 8 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 abandoned, 1 cancelled.

What trademark classes does Aedicell, Inc file in?

Aedicell, Inc files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Aedicell, Inc's most well-known trademarks?

Aedicell, Inc's registered trademark portfolio includes well-known marks such as AEDICELL, DERMAVEST, PLURIVEST, and FROM LIFE. FOR LIFE.. These are among 4 currently registered trademarks in the portfolio.

What is Aedicell, Inc's trademark registration success rate?

Aedicell, Inc has a 50% trademark registration rate, with 4 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.